🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Not every day that you get to celebrate a years-long survival advantage in the treatment of small cell lung cancer!!! Mind-blowing to see the median overall survival for limited stage SCLC approach the oncologically conventional 5-year milestone #lcsm #ASCO24

Future of medical oncology in Ireland is bright ✨️ Delighted to present these trainees with their certificates of completion of medial oncology training Royal College of Physicians of Ireland

We're just one week out from the ISMO after ASCO meeting (online). Registered? If not 📩 [email protected] Full agenda is available here: bit.ly/4eDIv39 Seamus O’Reilly MD PhD Jack Gleeson Siobhan Gaynor Caitríona Goggin Fergus Keane Eibhlin Mulroe 🌈 Angela Clayton-Lea

*JUST LAUNCHED* First of its kind ESMO Resilience Task Force special workshop. 🌍 Are you an oncologist working in Europe? Interested in making a change for yourself & your institutions/countries? 🗳️ Come join us in Barcelona in 2025 - for more info: esmo.org/meeting-calend…

Half of people with inherited BRCA1/2 mutations are men, yet very few men are offered genetic testing or know the importance to their own health. Article reviews data & screening recommendations aimed to help men take action to reduce their risk of cancer. ja.ma/4fcrjSF

"Patients who subscribe to alternative therapies are twice as likely to die in the same period as those who rely on conventional therapies..." Great commentary accompanying or new study: nature.com/articles/s4427… by Seamus O’Reilly MD PhD Dearbhaile Collins et al. Our study:

#YoungOncologists have been recurrently reported to be at high risk of #burnout. 💡Are there any other initiatives/suggestions which you think might be helpful? #ESMO4Carers Matteo Lambertini, MD PhD #ESMOYOC Mandy Lauw YoungEHA Dr Andrew Parsonson ausyoungoncs Young Oncologists Group India🇮🇳 Young SIOG

🌟 Don't miss out! Apply to come join us in Barcelona 🇪🇸 in 2025 in the *first* dedicated #ESMORTF 2-day interactive workshop - deadline 22 Sep 2024. #ESMO4Carers ESMO - Eur. Oncology 🗳️ esmo.org/meeting-calend…

Informative session on CUP #ESMO24 ESMO - Eur. Oncology Natalie Cook 💙 with recent publication of CUPISCO trial leading to changes in ESMO guidelines; benefit of molecularly guided therapies and importance of molecular profiling The Christie NHS Manchester Cancer Research Centre

ESMO Resilience Task Force Special Session.... sharing the recommendations & panel discussion on next steps

Peter Schmid presents the OS data from KN522 #ESMO24 publl now in NEJM. >6 year FU: 9% EFS benefit, 5% ⬆️OS with pembro pre/post op for TNBC. Pts with PCR had 95% survival +/-pembro but 6% ⬆️OS in nonPCR + pembro. Safety same. Huge advance for TNBC. Need biomarkers! OncoAlert

Thanks to great panel and audience ESMO - Eur. Oncology #RTF #ESMO24 forum addressing burnout and resilience together. Join us at the first resilience ESMO workshop in Barcelona 31st Jan/1st Feb 2025 #ESMO4Carers

#ESMO24 Natalee 4 yr update with increasing benefit in all subgroups c/w carryover effect. 36% <3 yrs; 20% due to AEs. 8.6% gr 3+ LFTs AEs. Nitrosamine issue 2b imminently resolved. Exciting advance for mod/hi risk ES HR+ BC. OncoAlert

Great to hear insights directly from our #ESMORTF expert in Organisational Health & Wellbeing at the ‘Policy & Preventative Strategies’ track #MiniOral session today. Watch the space for the full report soon! #ESMO24 #ESMO4Carers #ESMOAmbassadors

Winners get cake, Darren J. Walsh (hosp pharmacist of the year) Deirdre - Aseptic Services Team rep (finalist) Dr. Ann Horgan Consultant Med Onc (preceptor) with Darren #pharmacyteam #workingtogether HSE Dublin and South East HSE/SECH (now part of HSE Dublin and South East) HSE Ireland NAS_Waterford

#INAVO120, which led to the approval of inavolisib for HR+/HER2- MBC, is now published in NEJM. Strong data, with doubling of PFS & ORR by adding inavo to fulv/palbo among high-risk patients (with PIK3CA mut & early recurrence). Non-negligible toxicities. nejm.org/doi/full/10.10…

Another great day for the St Luke’s Radiation Oncology Network as the first patient is treated with liver SABR. A truly multidisciplinary venture and dedicated team. Congratulations 🙌 ⁦NCCP⁩ ⁦HSE Dublin and Midlands⁩ ⁦HSE Ireland⁩ ⁦Irish Cancer Society⁩

Honoured to accept an award at the inaugural HSE Patient Flow Excellence Awards on behalf of the incredible team leading out on a radiographer-led PICC service in UHW, improving access to care for patients & championing #advancedpractice #PFA24 UHW_RAD Univ Hosp Waterford Iirrt

Great to see our young ones at the ESMO Lung Preceptorship 🫁 🇫🇷 Thanks ESMO - Eur. Oncology for your commitment to training the next generation 🇮🇪 Beaumont RCSI Cancer Centre RCPI_Trainees RCSI #LCSM